chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills, headache experienced 1 day after vaccination; Chills, headache experienced 1 day after vaccination; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the parent.  A 16-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), CHILLS (non-serious), outcome "unknown" and all described as "Chills, headache experienced 1 day after vaccination".  No follow-up attempts are possible. Information on lot/batch number cannot be obtained. No further information is expected.
Experienced chest pain 4 days after the vaccine; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHEST PAIN (Experienced chest pain 4 days after the vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Experienced chest pain 4 days after the vaccine). At the time of the report, CHEST PAIN (Experienced chest pain 4 days after the vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment medications were provided. Patient mentioned that his doctor told him that three cases especially in young male adults, they experienced same adverse event as chest pain after 4 days of vaccine administration.   Most recent FOLLOW-UP information incorporated above includes: On 01-Oct-2021: follow up received contains non-significant information.
About two-weeks after my first dose of the Moderna vaccine, I started getting a dent in my skin on the top of my left big toe. It was red and felt like the skin was being sucked downward. The other toes looked like they may have small perforations on them too (yet not red). I have been healthy otherwise. I have never had covid-19 symptoms until this toe pain.
mucus; Allergy; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient family member or friend and describes the occurrence of SECRETION DISCHARGE (mucus) and HYPERSENSITIVITY (Allergy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SECRETION DISCHARGE (mucus) and HYPERSENSITIVITY (Allergy). At the time of the report, SECRETION DISCHARGE (mucus) and HYPERSENSITIVITY (Allergy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by the reporter.  The reporter noted the patient received the first dose of mRNA-1273 a month prior to the event.  Treatment information was not provided.
Fever (T =?), irritability, some loss of appetite x 24 hours or less.
This spontaneous report as received from a healthcare student refers to a patient of unknown age and gender. On 10-SEP-2014 the patient was vaccinated with PROQUAD INJ (route, dose no, dosage and lot number unknown). The healthcare student reported that the patient received improperly stored PROQUAD instead of M-M-R. PROQUAD was found to be unsupported by in-house stability data. No adverse symptoms reported. Additional information has been requested.
This study case was received from the investigator in a trial on 22 February 2012. A subject (age, date of birth and gender not reported) had received an injection of ACAM2000 (lot number, route, site and date not reported). The subject was diagnosed with unspecified disease of pericardium on 08 December 2011. Medical history was not reported. No further information was available at the time of the report. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Documents held by sender: None.
Head turned to the right, tonic stiffening or right arm, and eyes blinking. Stated that event lasted for around 5 min, but not longer than. Afterwards slept for several hours.
This spontaneous report as received from a physician via company representative refers to a patient of unknown age and gender. No information on patient's pertinent medical history, drug reactions or allergies was provided. On 01-MAR-2016, the patient was vaccinated with the first dose of GARDASIL 9 intramuscularly (dose, lot # and expiry date were not provided). On 11-AUG-2016 and 13-OCT-2016, the patient was intramuscularly vaccinated with the second and third dose of GARDASIL 9 (dose, lot # and expiry date were not provided), respectively. Additional information has been requested.
Information has been received from a registered nurse concerning a 16 year old female with no known drug reaction/allergies and no pertinent medical history, who on 04-NOV-2008 was vaccinated with the first dose of GARDASIL, 0.5ml, intramuscularly and on 03-APR-2009, was vaccinated with the second dose of GARDASIL, 0.5ml, intramuscularly.  There was no concomitant medication. The registered nurse reported that the patient experienced pain at the site of GARDASIL administration. It was noted that the patient returned late for the second dose of the vaccine. The lot number of the first dose was not available. On an unspecified date, the patient recovered. The patient sought medical attention and spoke to the nurse's practice. Additional information has been requested.
I am submitting on behalf of my husband.  He started "feeling strange" around 5pm.  At first he said he felt uneasy and he then later described feeling "like he was tripping".   He later started feeling confused.  He went to bed around 11p.m. and woke up feeling very tired and achy but was also having a lot of trouble concentrating.  Later in the evening he was acting very confused and he didn't look well at all.  He was having difficulty verbalizing and conveying his thoughts, he couldn't remember words and at one point he actually called me "mom".  I am concerned.  He said he would contact the hotline for adverse reactions on 2/26 if he still felt the same, but I felt it was important to report it either way.  He has never behaved this way before and has no medical history of any sort of memory or mental issues.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57-year-old male patient received BNT162b2 (BNT162B2), on 25Feb2021 at 09:00 as dose 1, single (Lot number: EN6203), in left arm, on 18Mar2021 at 14:00 as dose 2, single (Lot number: EN6207), in left arm, on 02Oct2021 at 14:00 as dose 3 (booster), single (Lot number: 301458A), in left arm and on 06Apr2022 at 14:00 as dose 4 (booster), single (Lot number: FJ9943) at the age of 56 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "hypertension" (unspecified if ongoing); "hyperlipidemia" (unspecified if ongoing); "benign prostatic hyperplasia" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results, notes: COVID 19 Treatment; (14Jun2022) Negative, notes: initially tested negative one day after completion of treatment; (17Jun2022) Positive, notes: I initially tested negative one day after completion of treatment and then tested positive four days later. Therapeutic measures were taken as a result of covid-19.
Information has been received from a nurse concerning her 18 year old daughter who was vaccinated with the second and third doses of GARDASIL two years ago (in approximately 2006).  After receiving her second and third doses of GARDASIL the patient experienced fever and pain at the injection site two years (in approximately 2006).  Lot number was not available.  The outcome was unknown.  The patient sought unspecified medical attention.  Additional information is not expected.
Information has been received from the authors of a published literature article concerning an 8 month old male with a history of pyelonephritis who on an unspecified date was vaccinated with his second dose of HIB conjugate vaccine. There was no concomitant medication. Subsequently, he presented to the clinic with 1 day of fever to 39.4 degrees C and refusal to move his left leg. The patient was hospitalized. Ceftriaxone was given. Joint fluid cultures grew H. influenzae type A. Blood cultures were sterile. He became afebrile on day 2 of antibiotics and was well at the time of discharge. He completed 3 weeks of ceftriaxone treatment. Three months later, the patient was again evaluated because of fever to 41.1 degrees C, and refusal to use his left leg and left arm. Ceftriaxone and vancomycin were started. Blood and joint fluid from his elbow and hip grew H. influenzae type a. He became afebrile on day 5 of treatment. He completed 4 weeks of ceftriaxone therapy and recovered completely. No further information is available.
Swollen Lymph node in neck on the side of the injection (right side). I noticed on June 3 , two days after the vaccination. I woke up and the node was huge and sore/itchy.
site of injection r)arm c/o discomfort today. Fever on 08/28/08 of 102.Temp today 99.2.Exam shows 4x3" area of erythemia at site of pneumovax vaccine.
Ongoing issues with migrating joint and muscle aches. Initially I took  advil. After 2 weeks my GP prescribed a medrol dose pak that got rid of symptoms immediately and for the duration of the treatment. When the meds were over the symptoms came back to a lesser degree. The symptoms are persistent to this day. I presently take 2 tylenol usually twice a day and I am comfortable but still have slight malaise. I am due for second shot on the 29th. A little worried
Body aches. sharp pain in finger joints. Sharp pain in joints. Pain in bones. Fatigue. Pain at injection site. Swollen painful lymph nodes in the armpit of the same arm of the injection site. Headache after 24 hours. Neckache. Shoulder pain.
fever, chills, myalgia, malaise, tx w/APAP & fluids, bed rest;get a thermometer & monitor temp
This spontaneous report as received from a healthcare worker refers to a 2 year old patient of unknown gender. On 31-JAN-2014 the patient was vaccinated with VARIVAX (Merck), lot # H018014, expiration date 01-OCT-2014, 0.5 ml once, subcutaneous (dose in series unspecified) that was improperly stored at 11.5F due to defrost cycling for an unspecified time frame. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
one week after vaccination, I was very tired by 6:00 PM.  I awoke this morning with a warm arm that is super itchy.  I am tired again today.
A few days before I got diagnosed, I noticed some irritation in my throat. I thought it was just dry air. I felt better a few hours later. The next day I felt worse. On the 23rd I was feeling significantly worse. I went and got a rapid test, and it was positive. I looked up clinics that might be open and we found one. They tested us again and it came back positive. I asked for the Paxlovid prescription. My throat felt pretty bad. I had trouble sleeping. It was mainly discomfort that I felt. I started feeling better before the tests. I started running outside before I got a negative. The symptoms went away, and it seemed like they were coming back. I got a little blood on the swab and thought it was a false positive, but I did it again and it was positive. I stopped working out outside for a couple of days. I also think that I might have had brain fog but I'm not sure.
I suffered from high fever of 103, early 12/02/17, By midday 12/02 chills, body aches, pounding headache, nasal burning, hacking cough (worst at night) but consistent, my joints and muscles were stiff, weakness, and trouble breathing all through 12/06. Low grade fever on 12/06/17, cough worsened, hard time breathing and chest tightness, diarrhea, my chest hurt really bad.
Headache, Myalgia, Arthralgia, Angioedema, Nausea Vomiting & HYPOtension Narrative: Extensive >4 days symptoms, lost work time
selected 2 vials of Adjuvant/ were never mixed/Medication error intercepted; This case was reported by a pharmacist via call center representative and described the occurrence of intercepted drug prescribing error in a adult patient who received Herpes zoster (Shingrix) (batch number 2EC54, expiry date 11th November 2022) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced intercepted drug prescribing error. On an unknown date, the outcome of the intercepted drug prescribing error was unknown.  Additional details were reported as follows: The age at vaccination was not applicable for this report. The age group was not reported but was captured as adult as per vaccine indication. Reporter stated that she was about to prepare a Shingrix vaccine by error selected 2 vials of Adjuvant Suspension Component (liquid). Product vials were never mixed ( batch number 2EC54, expiry date 11th November 2022 ) which led to intercepted drug preparation error The reporter consented to follow up.
Acute - Got Johnson & Johnson COVID-19 vaccine this past Thursday  - Thursday night starting cramping with abdominal pain radiating to the back; remained quite bothersome through Friday, Saturday, Sunday  - Had nausea but no vomiting; mild HA - Some episodes of loose stools but no blood - No fever and chills but some diaphoresis  - Has been drinking water but not eating  - Has been a little bit of SOB and dyspnea on exertion  - No lightheadedness, syncope or near syncope; no palpitations or chest pain  - No clear alleviating factors, worsens when he drinks too much water  - no recent history of alcohol intake
Upper left shoulder and arm  got stiff and sore, felt tough, slow motivation after 12 hours of receiving vaccination.  Took 2- 4  Aspirin to release symptoms.
Patient started coughing within about 5 minutes of getting his shots.  Felt like he was going to throw up, some dry heaving.  Belly hurt, smear of loose stool .  Throat felt tight.  Lungs clear prior to shots but diffuse wheezing and mild retractions after.  Pulse always brisk.  Got 2.5 mg albuterol and 0.5 mg atrovent nebs, 0.15 mg epi pen jr, and 10 ml of liquid benadryl.  EMT arrived and transported him Hospital for further managment.  Known egg allergy but not anaphylactic.  Has had both MMR and flu shots in the past with no problems
This spontaneous report was received from a certified medical assistant, referring to an unspecified number of patients. Ages, genders, medical history or concurrent conditions were not reported, Since 08-SEPT-2015, an unspecified number of improperly stored doses of GARDASIL 9 (lot # L016428) were inadvertently administered to the unspecified number of patients. No adverse effects have been reported. The reporter refers that was not product quality complaints involved. Additional information has been requested.
Pt received HPV vaccine, hive noticed, then began to increase to multiple hives and redness. Pt had itching  to arms and legs then itching to throat. Pt seen by provider, benadryl give as 2 separate doses. Pt was not improving 911 was called.
Weakness, feeling hot, facial swelling generalized urticaria - went to a treatment center - was given prednisone (dose pack), PEPCID, and BENADRYL.
patient complains of rash (pinpoint macules) on chest by Thursday evening (9/24/25) this morning it spread to both shoulders.
Bilateral pulmonary embolism, Left Brachial artery clot, abdominal clots
Starting 09/20/2022, I developed a slight headache, severe muscle cramps and muscle aches in the neck, shoulder and right arm. I developed joint pain in the right side (knee, hip, shoulder). It lasted for a few weeks and I scheduled an appointment with the PCP. They said it was likely stress related and told me to continue doing hot tub, massage, and prescribed me cyclobenzaprine. I have residual discomfort in my right hip. I had been diagnosed with arthritis in my neck a few years ago and sometimes I get flare ups; however, I knew it wasn't a flare up because it usually doesn't last this long.
had severe pain in arm... hard hot spot from shoulder to elbow. went to bed woke up just after midnight shaking/very cold/burning up   felt like I was going to be sick ended up have violent diarrhea and throwing up, all the while shaking uncontrollably. went on until almost 5am
Patient complained of chest tighness about 20 minutes after vaccine.  Benadryl 25mg given, BP 220/120.  Pepcid 40mg po, Xyzal 5mg po, and tylenol 975 po given for headache.   Patient given Toradol 30mg IM for continued complaints of chest tightness.  patient monitored for 3 hours.
Pfizer-BioNTech COVID-19 Vaccine EUA Within approx. four hours of receiving the vaccine, I had several red welts develop on my abdomen. Over a period of several days, these welts spread to my back and were angry, red and painful.  Since then, they have blistered. I went to a walk-in clinic because my primary care physician clinic was closed due to lack of power.  At the walk-in clinic, I was diagnosed as having shingles.  I had the shingles vaccine in 2014. I am now taking Acyclovir 800 mg five times per day. I am also taking L-Lysine with meals and Oxycodone-acetaminophen for pain.
DIARRHEA, MALAISE, LETHARGY, WEAKNESS, FATIGUE, LOSS OF APPETITE, SWOLLEN GLANDS, ROSACEA.
Patient reported to office on 02/19/2019. Patient had only ever received Hep #1 shortly after birth, no other vaccines have ever been administered. QUADRACEL (DTaP-IPV) administered as first dose to unvaccinated patient at this visit. No adverse events reported from parent. Per CDC, it will count in series but DTaP, and IPV should have been administered separately as this was the patient's first dose of DTaP and IPV. Advised to complete VAERS.
Known environmental and fruit allergies.  Pt c/o Dizziness, flushing/sweating, nausea, "throat feels swollen" w/ concerns that it might close. VSS, no allergic reaction evident today.  Given 50mg PO Benadryl.  Patient stable and released from vaccination site.
No adverse event. After the vaccine requested was administered, it came to my knowledge the patient had not completed her primary series, she had only received her first dose of Pfizer a year ago. As a result, contacted CDC on recommendation, which is to receive a dose of monovalent Moderna in order to be considered up to date, then the booster again at least 2 months after. Made this recommendation to the patient and made patient's primary care doctor aware.
102F fever, cramps legs, very heavy period, body pain, headache, arm hand pain, feet cramps, stomach cramps
developed full body rash; Doctor said it is overactive immune system.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID:. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series completed; unknown manufacturer), for COVID-19 immunization. The following information was reported: RASH (non-serious), outcome "unknown", described as "developed full body rash"; IMMUNE SYSTEM DISORDER (non-serious), outcome "unknown", described as "Doctor said it is overactive immune system.".  The information on the batch/lot number for [BNT162B2, BNT162B2 OMI BA.4-5] has been requested and will be submitted if and when received.
pt recv vax 7OCT96 & 8OCT96 pt exp a temporal h/a;9OCT96 pt became real dizzy;As the day progressed & pt exp some chills, felt very tired & face felt hot;
Baseball size rash across R arm; Redness with purple center; Warm to touch; Red line at bottom of Rash; Pain when pressed; Nausea; Fever for two days; This case was reported by a other health professional via call center representative and described the occurrence of rash in a 51-year-old female patient who received Herpes zoster (Shingrix) (batch number EE924, expiry date 29th January 2022) for prophylaxis.   On 18th October 2019, the patient received the 1st dose of Shingrix. In October 2019, less than a week after receiving Shingrix, the patient experienced rash, skin discolouration, skin warm, red rash, pain, fever and nausea. On an unknown date, the outcome of the rash, skin discolouration, skin warm, red rash, pain and nausea were unknown and the outcome of the fever was recovered/resolved.   It was unknown if the reporter considered the rash, skin discolouration, skin warm, red rash, pain, fever and nausea to be related to Shingrix.  Additional details were provided as follows: This case was reported by the pharmacy student. The patient received shingrix on the right arm. The patient experienced baseball size rash with purple center around injection site which was increased daily and that extends across the right arm. At the bottom of the rash, there was a red line. Warm to touch and pain when pressed. Fever lasted for 2 days. The reporter did not consent to follow up.
2nd GARDASIL injection occurred 1/29/14. Pt reported stomach pain after injection as well as skin scabbing and scarring at injection site.
Soreness at injection spot; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Feb2021 at 08:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included "blood Leiden factor V". The patient had no allergies to medications, food, or other products. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), acetylsalicylic acid (BABY ASPIRIN), ergocalciferol (VITAMIN D) and probiotics; all taken for unknown indications from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Feb2021 at 15:00, the patient experienced soreness at injection spot. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event soreness at injection spot was resolved on an unknown date in Feb2021. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via unspecified route of administration in the left arm on 25Feb2021 at 08:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.